NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SpineX Inc.

SpineX Inc.

Private
Fremont, CaliforniaHealthcare & Life Scienceshttps://spinex.co/

Last Round

Grant

Sep 26, 2023

Total Funding Raised

$10.47M

Company Overview

SpineX Inc. is a clinical-stage medical technology company that develops non-invasive spinal cord neuromodulation devices to treat neurological conditions such as neurogenic bladder and cerebral palsy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neuromodulationspinal cord stimulationmedical devicebioelectric medicinenon-invasive stimulationneurorehabilitationbioelectronic medicinetranscutaneous electrical stimulationneurogenic bladder treatmentcerebral palsy therapyparalysis recoveryFDA breakthrough deviceclinical rehabilitationmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SpineX Inc. Comps

Public and private peers based on sector, stage, and business model.

SpineX Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SpineX Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 26, 2023
AcceleratorAug 18, 2023
SeedAug 4, 2023
Convertible DebtMar 31, 2023
GrantFeb 28, 2022

Key People

Founding team and executive leadership

Parag Gad

Co-Founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    Monthly visitors increased 157% MoM, reaching 4.2K.

  • Feb 28, 2022

    $256K grant received from the National Science Foundation.

SpineX Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SpineX Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SpineX Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersFremont, California
Employee Range7
Year Founded2018
Last FundingSep 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.